当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析

博瑞医药

(688166)

  

流通市值:219.51亿  总市值:219.51亿
流通股本:4.23亿   总股本:4.23亿

博瑞医药(688166)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.31亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益253171.84万元,未分配利润97597.24万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产536007.00万元,负债282835.16万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入874,249,705.24537,438,662.14248,959,843.431,282,551,614.5
营业总成本859,671,361.36549,542,369.7266,560,026.021,102,598,723.72
其他经营收益
营业利润22,773,286.49-4,822,123.74-11,896,358.17160,289,049.93
利润总额22,414,798.66-5,021,225.35-11,863,878.89157,200,608.4
净利润31,386,524.751,657,076.47-4,656,771.18141,263,284.54
每股收益
其他综合收益-2,579,713.14-2,579,713.14-70,221.14-37,833,359.39
综合收益总额28,806,811.61-922,636.67-4,726,992.32103,429,925.15
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,466,597,706.531,543,927,667.971,571,596,585.711,640,277,766.14
非流动资产:
非流动资产合计3,893,472,334.773,839,866,910.553,713,676,711.13,516,240,676.75
资产总计5,360,070,041.35,383,794,578.525,285,273,296.815,156,518,442.89
流动负债:
流动负债合计1,167,050,820.961,157,002,452.45938,194,263.591,052,385,357.52
非流动负债:
非流动负债合计1,661,300,790.681,640,625,190.991,731,062,179.251,678,103,094.39
负债合计2,828,351,611.642,797,627,643.442,669,256,442.842,730,488,451.91
所有者权益(或股东权益):
归属于母公司股东权益合计2,448,042,214.542,474,316,681.222,501,618,781.222,383,301,688.47
股东权益合计2,531,718,429.662,586,166,935.082,616,016,853.972,426,029,990.98
负债和股东权益合计5,360,070,041.35,383,794,578.525,285,273,296.815,156,518,442.89
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计822,177,913.94562,391,959.6317,907,169.841,117,870,607.02
经营活动现金流出小计723,223,052.13448,779,178.59210,914,177.33872,311,289.92
经营活动产生的现金流量净额98,954,861.81113,612,781.01106,992,992.51245,559,317.1
投资活动产生的现金流量:
投资活动现金流入小计46,724,294.4246,722,764.426,160155,841,559.42
投资活动现金流出小计599,293,366.52434,025,408.32227,303,774.99595,983,083.56
投资活动产生的现金流量净额-552,569,072.1-387,302,643.9-227,297,614.99-440,141,524.14
筹资活动产生的现金流量:
筹资活动现金流入小计965,002,925.81748,699,300518,151,900926,077,074.15
筹资活动现金流出小计671,336,996.93504,588,160.26348,760,914.55950,551,978.01
筹资活动产生的现金流量净额293,665,928.88244,111,139.74169,390,985.45-24,474,903.86
汇率变动对现金及现金等价物的影响6,062,765.146,309,982.473,123,026.272,118,247.62
现金及现金等价物净增加额-153,885,516.27-23,268,740.6852,209,389.24-216,938,863.28
期末现金及现金等价物余额600,216,414.68730,833,190.27806,311,320.19754,101,930.95
补充资料:
现金及现金等价物的净增加额--23,268,740.68--216,938,863.28
最新报告期:2025-09-15
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东吴证券朱国广0.620.721.032025-09-15
TOP↑